Pathology: p53 tumor suppressor gene mutation, loss of heterozygosity (LOH) at 11p15 locus. PAX-FKHR genefusion.
病理学：p53肿瘤抑制基因突变，第11p15基因座杂和性丢失。
2
Using genefusion technology, polypeptide fusion tags can be engineered into target proteins at the genetic level.
多肽融合标签能够赋予目标蛋白新的特性，便于目标蛋白的定位、追踪、纯化以及结构和相互作用研究。
3
The principles, operation and applications of site-directed mutagenesis, genefusion technology, and post-translational modification methods were introduced emphatically.